NV
Nimmagadda Venkata Anirudh
管理人员
Other
Explore the detailed record of transactions filed by Nimmagadda Venkata Anirudh, 管理人员. Insider active across 1 company, notably Divi's Laboratories Limited. Aggregated, 14 reports have been recorded. History available since 4 June 2021. The latest transaction was disclosed on 19 March 2025 (Sale). Regulator: SEBI (PIT + SAST). The full history is openly available.
Companies and markets linked to Nimmagadda Venkata Anirudh
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报14 总计
25,000 股@ ₹5,781.15239.0% 占其流量Equity SharesSEBI:63e82fc7f1f932dd0800e2c1b5815c25e2a61a1b
13,808 股@ ₹5,014.64594.4% 占其流量Equity SharesSEBI:795f62fc1bc3951d1b1cbdd194543e516dc6fe87
10,000 股@ ₹4,927.503.1% 占其流量Equity SharesSEBI:ce9e727bc47638d35a9e129d152db18f9fdcdd65
5,000 股@ ₹4,520.001.5% 占其流量Equity SharesSEBI:cc425db059ef90087ad117911e840845391326de
10,000 股@ ₹4,597.503.0% 占其流量Equity SharesSEBI:fd934615436689aa5f913c815bb060182e710d58
30,000 股@ ₹3,734.22617.4% 占其流量Equity SharesSEBI:261e9e2ffe640eb4b597b7d4769cdd5d28738ff3
27,500 股@ ₹3,647.74646.5% 占其流量Equity SharesSEBI:563db26321ad0d788c5cfdcf3c2e171c048ec2fa
11,500 股@ ₹3,622.19532.7% 占其流量Equity SharesSEBI:63ba834c9689b9c27dd3efb18e4a5840005e784c
237,340 股@ ₹3,430.0054.6% 占其流量Equity SharesSEBI:08800f686f29ade06b0d21ce982b0b260c980a16
5,000 股@ ₹4,366.37580.0000% mcap18.6% 占其流量Equity SharesSEBI:13722fc9899bb60b9035c82f8a80781b796e70d2
10,000 股@ ₹4,284.05190.0000% mcap36.4% 占其流量Equity SharesSEBI:4426f6094a9327622e194c2144db177da2821349
7,500 股@ ₹4,229.00360.0000% mcap27.0% 占其流量Equity SharesSEBI:0c5da76026626de57e3a4a3150a9125c614a4bd1
2,500 股@ ₹4,240.59440.0000% mcap9.0% 占其流量Equity SharesSEBI:4671322f68268693f8ed9a5127446c9829e572a3
2,500 股@ ₹4,240.59440.0000% mcap9.0% 占其流量Equity SharesSEBI:04f61155c2f3e63a40df50ef96608451af148b0f
About Nimmagadda Venkata Anirudh
Nimmagadda Venkata Anirudh is an executive at Divi's Laboratories Limited. In this role, he is responsible for managing the operations and strategy of the company, which is a major player in the pharmaceutical sector. His leadership is essential for the growth of Divi's Laboratories Limited.